Brief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
March 15 (Reuters) - Sio Gene Therapies Inc SIOX.O :
* SIO GENE THERAPIES INC - ON MARCH 14, GOT NOTICE THAT
NASDAQ HAS
DETERMINED THAT COMPANY'S COMMON STOCK WILL BE DELISTED FROM
NASDAQ CAPITAL MARKET
* SIO GENE THERAPIES INC - IN LIGHT OF COMPANY'S PLANNED
DISSOLUTION, COMPANY WILL NOT APPEAL THIS DETERMINATION
Source text: [ID:https://m5.gs/WkhMcD]
Further company coverage: SIOX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results